The risk of thrombotic events in carriers of IgA-aB2GP1 is higher for carriers of other thrombosis-associated risk factors such as smoking, infections, prolonged immobilization, use of estrogens, or surgical procedures (27). This evidence concerns the gene CD79A and deep vein thrombosis.